•
Dec 31, 2019

Tenet Healthcare Q4 2019 Earnings Report

Tenet Healthcare's Q4 2019 financial performance was reported, showcasing increases in key financial metrics and patient volumes.

Key Takeaways

Tenet Healthcare reported a net income of $2 million, or $0.02 per diluted share, in 4Q19, compared to a net loss of $5 million, or $0.05 per diluted share, in 4Q18. Adjusted EBITDA was $805 million, up from $684 million in the prior year, and adjusted diluted EPS increased to $0.99 from $0.51 in 4Q18. The company anticipates a spin-off of its Conifer segment by the end of the second quarter of 2021.

Consolidated Adjusted EBITDA increased by 18 percent year-over-year.

Consolidated Adjusted diluted EPS rose by 94 percent year-over-year.

Hospital segment same-hospital admissions and adjusted admissions grew by 2.6 percent and 1.9 percent, respectively.

Ambulatory segment system-wide same-facility surgical cases increased by 3.4 percent.

Total Revenue
$4.81B
Previous year: $4.62B
+4.0%
EPS
-$0.03
Previous year: -$0.05
-40.0%
Admissions growth
2.6%
Previous year: -2.7%
-196.3%
Adjusted Admissions growth
1.9%
Previous year: -0.8%
-337.5%
Gross Profit
$4B
Previous year: $3.86B
+3.6%
Cash and Equivalents
$262M
Previous year: $411M
-36.3%
Free Cash Flow
$342M
Previous year: $37M
+824.3%
Total Assets
$23.4B
Previous year: $22.4B
+4.2%

Tenet Healthcare

Tenet Healthcare

Tenet Healthcare Revenue by Segment

Forward Guidance

Tenet provided its outlook for FY 2020, anticipating continued growth from operational improvements.

Revenue & Expenses

Visualization of income flow from segment revenue to net income